VEGFR2 is a biomarker for cardiovascular disease and tumor research.
Citations: Zhen Sun, MD, et al. "Increased Serum Level of Soluble Vascular Endothelial Growth Factor Receptor-1 Is Associated With Poor Coronary Collateralization in Patients With Stable Coronary Artery Disease" Circulation Journal Vol.78, May 2014